Vojvodić Zeljko, Stimac Danijela
Coll Antropol. 2014 Dec;38 Suppl 2:73-8.
Prescribing of statins showed an increasing trend in all developed countries, during the last two decades. The aim of this study was to research the trends in statin consumption in the period from 2004 to 2012 as well as trends of cardiovascular mortality during the 1990 to 2012 period, and to compare them between Croatia and several neighbouring countries. Data on statin expenditures and consumption expresed in defined daily doses per 1000 inhabitants per day (DDD/TID), were taken from annual reports of Croatian Agency for Medicinal Products and Medical Devices (HALMED). Data on crude mortality rates and standardized cardiovascular mortality rates, were taken from the Croatian Health Statistics Yearbooks. The utilization of statins increased by 196.7% during the observed period, with the highest consumption of atorvastatin and simvastatin. Financial expenditure of statins expanded at much faster rate in comparison with overall drug costs. Cardiovascular mortality rates decreased slightly, while maintaining higher level in comparison with some neighbouring countries.
在过去二十年中,他汀类药物的处方量在所有发达国家均呈上升趋势。本研究的目的是研究2004年至2012年期间他汀类药物的消费趋势以及1990年至2012年期间心血管疾病死亡率的趋势,并在克罗地亚与几个邻国之间进行比较。他汀类药物支出和以每千居民每日限定日剂量(DDD/TID)表示的消费量数据,取自克罗地亚药品和医疗器械局(HALMED)的年度报告。粗死亡率和标准化心血管死亡率数据,取自《克罗地亚卫生统计年鉴》。在观察期内,他汀类药物的使用量增加了196.7%,其中阿托伐他汀和辛伐他汀的消费量最高。与总体药品成本相比,他汀类药物的财政支出增长速度要快得多。心血管疾病死亡率略有下降,但与一些邻国相比仍维持在较高水平。